Biomarkers of Alzheimer's Disease
AssigneeKing's College London
InventorSimon Lovestone
Life of this patent
Estimating the term…
Abstract
A test for diagnosing Alzheimer's Disease comprises measuring levels of GSK-3 in cells or body fluid in a sample taken from a human subject. The test provides a relatively noninvasive method of diagnosing Alzheimer's Disease, and may be useful in predicting which individuals with mild cognitive impairment will develop Alzheimer's Disease.
Claims15
A method for the prognosis or diagnosis of Alzheimer's disease comprising measuring levels of GSK-3 in a blood sample taken from a human subject.
A kit for use in a test for the prognosis or diagnosis of Alzheimer's disease comprising an antibody to inactive GSK-3 and an antibody to active GSK-3.
(canceled)
11-12. (canceled)
Dependencies are inferred from the claim text.